Home > Insider Trading > Filing (0001055726-21-000034)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1055726	Inovio Pharmaceuticals Inc.	INO	Surgical & Medical Instruments & Apparatus (3841)	330969592

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1771498	Elizabeth Jacqueline Shea	660 W. Germantown Pike Plymouth Meeting PA 19462	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-25	16,667	$0.00	72,084	No	4	M	Direct
Common Stock	Disposition	2021-03-25	7,247	$9.06	64,837	No	4	F	Direct
Common Stock	Disposition	2021-03-26	4,710	$8.97	60,127	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2021-03-25	16,667	$0.00	16,667	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,666			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares will vest on March 25, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.